by Feldan, on Jun 27, 2018 4:02:16 AM
Seoul (South Korea) & Québec City (Canada) June 27, 2018 – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”) announced an agreement today granting GCLC exclusive rights to use …
Read Storyby Feldan, on Jun 4, 2018 8:22:05 AM
Our CEO François-Thomas Michaud and Strategic development director Vincent Menard are pleased to be in Boston this week for the BIO convention. They are looking forward to meeting with international …
Read Storyby Feldan, on May 29, 2018 10:32:24 AM
QUEBEC CITY, May 29, 2018 - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a peptide-based delivery method …
Read Storyby Feldan, on May 1, 2018 10:40:10 AM
Feldan Therapeutics’ Research Director, Dr. David Guay, will be attending TIDES: Oligonucleotides and Peptide Therapeutics Conference next week, May 7-10th at Hynes Convention Center in Boston. Come to chat with …
Read Storyby Feldan, on Apr 9, 2018 11:29:06 AM
Our CEO Francois-Thomas Michaud and Strategic Alliance Director, Vincent Ménard, MBA Ph.D. will be attending RESI2018 conference in Toronto, April 10th. Come and meet with them to discuss how Feldan …
Read Storyby Feldan, on Apr 5, 2018 9:58:14 AM
Read the new article on the Feldan Shuttle Technology published in PLOS One (April 2018) : http://journalsplosorg/plosone/article?id=101371/journalpone0195558 …
Read Storyby Feldan, on Mar 29, 2018 2:00:42 PM
QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan Therapeutics for a total amount of $1.2M. The funds …
Read Storyby Feldan, on Mar 16, 2018 10:39:49 AM
Feldan Therapeutics will be attending the Innate Killer Summit from March 27 to 29 in San Diego, CA, USA. Come and meet with our Business Development Director Meriem Benchabane and one of our …
Read Storyby Feldan, on Jan 17, 2018 9:26:41 PM
Read the new article on the Feldan Shuttle Technology published in Drug Development & Delivery edition on January 2018. download article : wwwdrug-devcom/Uploads/Public/January%202018%20WEBpdf …
Read Storyby Feldan, on Jan 15, 2018 8:16:15 AM
Combined Feldan Shuttle and Green Cross LabCell NK cell technologies will be used to develop hyperactive NK cell immunotherapies QUEBEC, Jan. 15, 2018 /CNW Telbec/ - Green Cross LabCell, involved in …
Read Story
2666, Boul. du Parc Technologique Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com